The Evidence Is In: Australia Recommends Breast Implant Ban
Executive Summary
The Therapeutic Goods Administration says it now has enough evidence to warrant cancelling, suspending and recalling a number of textured breast implants because of the potential risks of developing anaplastic large cell lymphoma.
You may also be interested in...
Worldwide Recall On Allergan Textured Breast Implants
Allergan PLC announced that it would take its Biocell textured breast implants and tissue expanders off the market worldwide shortly after the US FDA released additional information linking the use of the implants to a rare cancer.
France Bans Breast Implants Linked To Rare Cancer; Canada Close Behind
There is now enough safety evidence to merit withdrawing macro-textured and polyurethane-coated breast implants from the market, according to health product regulators in France and Canada.
Outlook Turns To Marketing Strategy After Scoring EU First For Ophthalmic Bevacizumab
Outlook Therapeutics’ intravitreally injected Lytenava has won the thumbs up from the European Medicines Agency. The company is assessing both direct commercialization of the product and partnering in Europe on a country-by-country basis.